Abstract:Urokinase-type plasminogen activator (uPA) and its cellular receptor (uPAR) mediate plasminogen activation. The uPA binds to uPAR with high affinity (Kd 0.1–1nM), thus localizing the generation of plasmin from plasminogen on the surface of a variety of cells. uPA-uPAR binding is also involved in other cellular functions and diverse pathophysiological processes such as tissue remodeling during wound healing, atherosclerosis, angiogenesis and tumor metastasis. We have determined the structure of uPAR complexed with the amino terminal fragment (amino acid residues 1–143) of uPA (ATF), which contains the uPAR binding domain, at 1.9 Å resolution by X-ray crystallography. Soluble uPAR (suPAR) and the ATF were expressed separately in stably transfected Drosophila Schneider 2 (S2) cells. The suPAR-ATF complex was crystallized by the sitting-drop vapor diffusion method. However, the diffraction of this crystal was limited to 3.1 Å resolution. Therefore, the Fab fragment of an antibody raised against suPAR, ATN-615, was used to facilitate suPAR-ATF crystallization. Crystals of the suPAR-ATF-ATN615 ternary complex were generated by microdialysis with 4% PEG4K, 5% ethylene glycol, 5% methanol, 0.05% sodium azide, 50 mM cacodylate pH 6.5. A complete data set of the ternary complex to 1.9 Å was collected using synchrotron radiation at the Advanced Photon Source (APS), Argonne National Laboratory. The crystals belong to the monoclinic space group, with unit cell parameters a=51.79 Å, b=86.81 Å, c=124.69 Å and β=94.54°. uPAR is comprised of three consecutive domains (D1, D2 and D3) that form the shape of a thick-walled teacup with a diameter of about 52 Å and a height of 27 Å. At the center of teacup and surrounded by three suPAR domains is a cone shape cavity with a wide opening (25 Å) and large depth (14 Å). ATF consists of a growth factor domain (GFD) and a kringle domain. Both domains pack more tightly in the complex structure compared with their unbound state. The GFD domain of uPA occupies part of the uPAR cavity and is primarily responsible for uPAR binding. The D1 domain of uPAR forms three hydrogen bonds and many hydrophobic interactions with the GFD domain of uPA, thus playing an important role in the binding of uPA. However, D2 and D3 of uPAR also have direct interactions with the GFD domain of uPA. The kringle domain of uPA sits outside the uPAR pocket, but forms some direct contacts with the D1 domain of uPAR. Therefore, the three domains of uPAR and two domains of uPA form a complementary interaction, which describes the structural basis for the high affinity binding of uPA to uPAR. This structure presents the first high resolution view of uPA-uPAR interaction, and may provide a new platform to design de novo uPA-uPAR antagonists.

Crystallization of Soluble Urokinase Receptor (supar) in Complex with Urokinase Amino-Terminal Fragment (1-143)

Crystal Structure of the Interaction of Human Urokinase Plasminogen Activitor with Its Receptor.

The Expression, Purification and Crystallization of Monomeric Soluble Human Urokinase Receptor

Crystal Structure of the Urokinase Receptor in a Ligand-Free Form

An Anti-Urokinase Plasminogen Activator Receptor (upar) Antibody: Crystal Structure and Binding Epitope.

Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor

Mapping the Topographic Epitope Landscape on the Urokinase Plasminogen Activator Receptor (upar) by Surface Plasmon Resonance and X-ray Crystallography.

Protein Expression and Preliminary Crystallographic Analysis of Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator

Crystal Structure of the Unoccupied Murine Urokinase‐type Plasminogen Activator Receptor (upar) Reveals a Tightly Packed DII–DIII Unit

Crystal Structures of Two Human Vitronectin, Urokinase and Urokinase Receptor Complexes

Crystal structure and cellular functions of uPAR dimer

Expression and Crystallographic Studies of the Ligand-Binding Region of the Human Endocytic Collagen Receptor Uparap

Optimization of Crystals of an Inhibitory Antibody of Urokinase Plasminogen Activator Receptor (upar) with Hydrogen Peroxide and Low Protein Concentration

Structure-Based Engineering Of Species Selectivity In The Interaction Between Urokinase And Its Receptor Implication For Preclinical Cancer Therapy

Mimicry of the Regulatory Role of Urokinase in Lamellipodia Formation by Introduction of a Non-native Interdomain Disulfide Bond in Its Receptor

Structural basis for therapeutic intervention of uPA/uPAR system

Stabilizing a Flexible Interdomain Hinge Region Harboring the SMB Binding Site Drives Upar into Its Closed Conformation.

Binding of human single chain urokinase to Chinese hamster ovary cells and cloning of hamster u-PAR

The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.

Progress in the Structural Study of Urokinase Receptor System

Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator